Application of 21-gene recurrence score in patients with T1-2, N0-1 ER-positive/HER2 negative breast cancer: Survival analysis in relation to clinical risk score

被引：0
|
作者：
Bae, Soong June [1 ]
Ahn, Sung Gwe [1 ]
Park, Soeun [1 ]
Cha, Chi Hwan [1 ]
Kim, Dooreh [1 ]
Lee, Janghee [1 ]
Jeong, Joon [1 ]
机构：
[1] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Seoul, South Korea
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
breast neoplasm; adjuvant treatment; 21-gene recurrence score; chemotherapy;
D O I：
10.1158/1538-7445.SABCS19-P3-08-68
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-08-68
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Does the 21-gene recurrence score have clinical utility in HR+/HER2+breast cancer?
    Bilani, Nadeem
    Crowley, Fionnuala
    Mohanna, Mohamed
    Itani, Mira
    Yaghi, Marita
    Saravia, Diana
    Jabbal, Iktej
    Dominguez, Barbara
    Liang, Hong
    Nahleh, Zeina
    BREAST, 2022, 66 : 49 - 53
  • [42] Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx Study
    Llombart-Cussac, Antonio
    Anton-Torres, Antonio
    Rojas, Beatriz
    Andres, Raquel
    Martinez, Noelia
    Rodriguez, Cesar A.
    Marin, Sara
    Puertolas, Teresa
    Gonzalez, Alejandro Falcon
    Fernandez-Murga, Maria Leonor
    Hagen, Carlos
    Ruiz-Borrego, Manuel
    CANCERS, 2023, 15 (05)
  • [43] A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
    Fujii, Takeo
    Masuda, Hiroko
    Cheng, Yee Chung
    Yang, Fei
    Sahin, Aysegul A.
    Naoi, Yasuto
    Matsunaga, Yuki
    Raghavendra, Akshara
    Sinha, Arup Kumar
    Fernandez, Jose Rodrigo Espinosa
    James, Anjali
    Yamagishi, Keisuke
    Matsushima, Tomoko
    Schuetz, Robert
    Tripathy, Debu
    Tada, Sachiyo
    Jackson, Rubie S.
    Noguchi, Shinzaburo
    Nakamura, Seigo
    Acoba, Jared D.
    Ueno, Naoto T.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (02) : 455 - 461
  • [44] 21 Gene Recurrence Score to Select for Patients with T3N0 ER+HER2-Breast Cancer Likely to Benefit with Postmastectomy Radiation
    Haque, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E4 - E4
  • [45] Multiparametric MR Imaging Radiomics Signatures for Assessing the Recurrence Risk of ER+/HER2-Breast Cancer Quantified With 21-Gene Recurrence Score
    Chen, Yang
    Tang, Wei
    Liu, Wei
    Li, Ruimin
    Wang, Qifeng
    Shen, Xigang
    Gong, Jing
    Gu, Yajia
    Peng, Weijun
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 58 (02) : 444 - 453
  • [46] Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer
    Dowsett, Mitch
    Sestak, Ivana
    Buus, Richard
    Lopez-Knowles, Elena
    Mallon, Elizabeth
    Howell, Anthony
    Forbes, John F.
    Buzdar, Aman
    Cuzick, Jack
    CLINICAL CANCER RESEARCH, 2015, 21 (12) : 2763 - 2770
  • [47] Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study
    LeVasseur, Nathalie
    Sun, Julia
    Fenton, David
    Baxter, Simon
    Chan, Angela
    Roberts, Sarah
    Feng, Xiaolan
    Lohrisch, Caroline
    Gelmon, Karen
    Shenkier, Tamara
    Chia, Stephen K.
    CLINICAL BREAST CANCER, 2022, 22 (01) : E74 - E79
  • [48] Validation of the 21-Gene Recurrence Score Assay in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer and 0 to 3 Positive Lymph Nodes: Risk Pattern and Outcomes on a Community Level
    Braun, Michael
    Kriegmair, Antonia
    Szeterlak, Nina
    Andrulat, Anne
    Schrodi, Simone
    Kriner, Monika
    Hanusch, Claus
    Hamann, Moritz
    Stoetzer, Oliver
    Poelcher, Martin
    BREAST CARE, 2022, 17 (03) : 288 - 295
  • [49] YAP1 Expression in HR+HER2-Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation
    Park, Inho
    Lee, Yangkyu
    Kim, Jee Hung
    Bae, Soong June
    Ahn, Sung Gwe
    Jeong, Joon
    Cha, Yoon Jin
    CANCERS, 2023, 15 (20)
  • [50] The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary tale from an NCDB analysis
    Weiser, Roi
    Haque, Waqar
    Polychronopoulou, Efstathia
    Hatch, Sandra S.
    Kuo, Yong-fang
    Gradishar, William J.
    Klimberg, V. Suzanne
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (03) : 667 - 676
12345